Spital Thurgau AG, Frauenfeld, Switzerland.
Anaesthesiol Intensive Ther. 2020;52(3):181-186. doi: 10.5114/ait.2020.98124.
Neuromuscular monitoring by acceleromyography assesses the effects of non-depolarising neuromuscular blocking agents used during anaesthesia induction to optimise intubation conditions. A new type of neuromuscular monitor, TOF-Cuff, integrates electrode stimulation into a blood pressure monitoring cuff. Comparisons of this device with TOF-Scan, considered a clinical standard acceleromyography device, have not been published.
This prospective, observational study was approved by the Ethics Committee East Switzerland (BASEC-nr. 2016-02044), and patients' consent was obtained before inclusion. The study's aim was to compare TOF-Cuff with TOF-Scan by measuring the duration from the administration of a neuromuscular blocking agent to a train-of-four (TOF) ratio of 0%. After anaesthesia induction, atracurium was administered (0.5 mg kg-1) and TOF ratios were recorded every 15 seconds using the two devices simultaneously. Patients were grouped according to body mass index (< or ≥ 30 kg m-2).
Twenty-five non-obese and twenty-five obese patients were included. In non-obese patients, bias was -3 s (± 21.2; limits of agreement -44.7 to 38.4; P = 0.702). In obese patients, bias was -20 s (± 35.0; limits of agreement -88.6 to 48.6; P = 0.0139). Large intra-individual differences of up to 60 seconds were detected even in non-obese patients.
A significant systematic difference in the time to reach a TOF ratio of 0% was found when using the two devices in obese patients. In non-obese and obese patients, there were large intra-individual and clinically relevant differences. The two devices cannot be used interchangeably.
肌动描记术通过加速肌电图监测非去极化神经肌肉阻断剂在麻醉诱导期间的作用,以优化插管条件。一种新型的神经肌肉监测仪,TOF-Cuff 将电极刺激集成到血压监测袖带中。尚未发表过这种设备与被认为是临床标准加速肌电图设备的 TOF-Scan 之间的比较。
这项前瞻性观察研究得到了瑞士东部伦理委员会的批准(BASEC-nr. 2016-02044),并在纳入前获得了患者的同意。该研究的目的是通过测量从给予神经肌肉阻断剂到四个成串刺激(TOF)比值为 0%的时间来比较 TOF-Cuff 和 TOF-Scan。麻醉诱导后,给予阿曲库铵(0.5 mg kg-1),并同时使用两种设备每隔 15 秒记录 TOF 比值。患者根据体重指数(<或≥30 kg m-2)分组。
纳入了 25 名非肥胖患者和 25 名肥胖患者。在非肥胖患者中,偏倚为-3 秒(± 21.2;一致性界限-44.7 至 38.4;P = 0.702)。在肥胖患者中,偏倚为-20 秒(± 35.0;一致性界限-88.6 至 48.6;P = 0.0139)。即使在非肥胖患者中,也检测到高达 60 秒的个体内差异很大。
在肥胖患者中使用两种设备时,达到 TOF 比值为 0%的时间存在显著的系统差异。在非肥胖和肥胖患者中,个体内差异很大且具有临床相关性。两种设备不能互换使用。